Menten AI
ActiveMenten AI designs peptide and protein therapeutics using quantum…
This company has previously operated under “Menten Biotechnology Labs”, “Inc.”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.
Founders · 2
TechBio startup founder with hands-on operational and finance experience. Working at the intersection of chemistry, biology, and computer science. Passionate about investing and value creation in the Life Science ecosystem. Outside of work, I enjoy several different sports activities, such as scuba diving, surfing, MTB, wakeboarding, and have 10 years of triathlon experience.
Related startups
We use AI to design antibodies for intractable diseases
We're training the next generation of protein foundation models.
